Literature DB >> 7583549

Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.

A R Miserez1, U Keller.   

Abstract

Familial defective apolipoprotein B-100 (FDB) is a recently identified autosomal-dominantly inherited disorder caused by a point mutation in the apolipoprotein (apo) B gene. To determine whether the phenotypic characteristics in FDB subjects are similar to those in subjects with familial hypercholesterolemia (FH), 76 kindreds fulfilling the clinical criteria for heterozygous FH/FDB were characterized using molecular biological techniques. Allele-specific polymerase chain reaction (PCR) at the apoB locus was used for diagnosis or exclusion of FDB. PCR-based methods for detection of two point mutations (V408M and P664L) at the LDL receptor (LDLR) locus, cosegregation analysis using eight restriction fragment length polymorphisms (RFLPs) at the LDLR locus, or the exclusion of FDB confirmed the clinical diagnosis of FH. Three kindreds were not included because of a missing cosegregation between a particular haplotype and the FH phenotype. We predicted that a similar number of kindreds would be detected in the two groups, assuming comparable prevalences of the diseases in our population and similar phenotypic characteristics. However, only nine kindreds were identified with the FDB mutation compared with 64 kindreds with FH (P < .0001). From these 73 kindreds, 28 FDB heterozygotes and 129 FH heterozygotes were compared using multivariate analysis. There were no differences between these two groups with respect to age, sex, and apoE genotype distribution, lipoprotein(a) concentrations, body mass index, blood pressure, and smoking habits. However, FDB subjects demonstrated significantly lower concentrations of total cholesterol (8.1 versus 10.2 mmol/L, P < .001), LDL cholesterol (6.3 versus 8.2 mmol/L, P < .001), and triglycerides (1.3 versus 1.8 mmol/L, P = .025) and higher concentrations of HDL cholesterol (1.4 versus 1.2 mmol/L, P = .015) than subjects with FH. In contrast to FH, female FDB subjects tended to have higher concentrations of total cholesterol (8.9 versus 7.5 mmol/L, P = .032) and LDL cholesterol (7.1 versus 5.7 mmol/L, P = .026) than FDB males. The same results regarding total and LDL cholesterol and sex differences were observed when individual data of 238 FDB and 415 FH subjects from the literature were compared. In addition, FDB subjects showed much larger total cholesterol fluctuations than FH subjects (median of intraindividual coefficients of variation: FDB, 14.5%; FH, 5.3%; P < .001). In summary, these results demonstrate that FDB subjects tend to have a milder form of hyperlipoproteinemia than FH subjects and that only a part of the subjects with FDB fulfill the established criteria for identifying FH.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583549     DOI: 10.1161/01.atv.15.10.1719

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  11 in total

Review 1.  Science, medicine, and the future: Genetics and cardiovascular risk.

Authors:  I N Day; D I Wilson
Journal:  BMJ       Date:  2001-12-15

2.  Familial hypercholesterolaemia.

Authors:  A David Marais
Journal:  Clin Biochem Rev       Date:  2004-02

3.  Use of homozygosity mapping to identify a region on chromosome 1 bearing a defective gene that causes autosomal recessive homozygous hypercholesterolemia in two unrelated families.

Authors:  E R Eden; R P Naoumova; J J Burden; M I McCarthy; A K Soutar
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

4.  A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32.

Authors:  M Varret; J P Rabès; B Saint-Jore; A Cenarro; J C Marinoni; F Civeira; M Devillers; M Krempf; M Coulon; R Thiart; M J Kotze; H Schmidt; J C Buzzi; G M Kostner; S Bertolini; M Pocovi; A Rosa; M Farnier; M Martinez; C Junien; C Boileau
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

5.  Molecular spectrum of autosomal dominant hypercholesterolemia in France.

Authors:  Marie Marduel; Alain Carrié; Agnes Sassolas; Martine Devillers; Valérie Carreau; Mathilde Di Filippo; Danièle Erlich; Marianne Abifadel; Alice Marques-Pinheiro; Arnold Munnich; Claudine Junien; Catherine Boileau; Mathilde Varret; Jean-Pierre Rabès
Journal:  Hum Mutat       Date:  2010-11       Impact factor: 4.878

Review 6.  Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs.

Authors:  Gamaleldin I Harisa; Fars K Alanazi
Journal:  Saudi Pharm J       Date:  2013-12-22       Impact factor: 4.330

7.  Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population.

Authors:  Khalid K Alharbi; Mohammed A Aldahmesh; Emmanuel Spanakis; Lema Haddad; Roslyn A Whittall; Xiao-he Chen; Hamid Rassoulian; Matt J Smith; Julie Sillibourne; Nicola J Ball; Nikki J Graham; Patricia J Briggs; Iain A Simpson; David I W Phillips; Deborah A Lawlor; Shu Ye; Stephen E Humphries; Cyrus Cooper; George Davey Smith; Shah Ebrahim; Diana M Eccles; Ian N M Day
Journal:  Genome Res       Date:  2005-07       Impact factor: 9.043

8.  Human LDL structural diversity studied by IR spectroscopy.

Authors:  José A Fernández-Higuero; Ana M Salvador; Cesar Martín; José Carlos G Milicua; José L R Arrondo
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

9.  Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity.

Authors:  J A Fernández-Higuero; A Etxebarria; A Benito-Vicente; A C Alves; J L R Arrondo; H Ostolaza; M Bourbon; C Martin
Journal:  Sci Rep       Date:  2015-12-08       Impact factor: 4.379

10.  New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia.

Authors:  Sandy Elbitar; Delia Susan-Resiga; Youmna Ghaleb; Petra El Khoury; Gina Peloso; Nathan Stitziel; Jean-Pierre Rabès; Valérie Carreau; Josée Hamelin; Ali Ben-Djoudi-Ouadda; Eric Bruckert; Catherine Boileau; Nabil G Seidah; Mathilde Varret; Marianne Abifadel
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.